From GlobeNewswire: 2025-03-11 16:05:00

Nature’s Sunshine Products, Inc. reported fourth quarter 2024 net sales up 8.5% to $118.2 million, with a GAAP net loss of $0.3 million. Full year 2024 net sales were up 2.0% to $454.4 million, with a net income of $7.7 million. CEO Terrence Moorehead highlighted strong growth in Asia Pacific and North America digital sales.

In the fourth quarter of 2024, Nature’s Sunshine saw an increase in net sales to $118.2 million, up 8.5% from the year-ago quarter. Gross margin improved to 72.0%, volume incentives rose to 31.1%, and operating income was $4.6 million. Other income (loss) was $(3.1) million, and GAAP net income was $(0.3) million.

Selling, general and administrative expenses in the fourth quarter of 2024 were $43.7 million, with a slight increase in SG&A expenses as a percentage of net sales. Adjusted EBITDA for the quarter increased to $10.3 million. Non-GAAP net income was $0.0 million, with adjusted net income at $10.3 million. Operating income was $4.6 million. In 2024, net sales increased 2.0% to $454.4 million, with a 3.8% increase excluding foreign exchange impact. Gross margin decreased to 71.5%, volume incentives rose to 30.9%, and SG&A expenses decreased. Operating income was $20.1 million, while other income (loss) was $(1.7) million. GAAP net income was $7.7 million.

Adjusted EBITDA in 2024 increased to $40.5 million, driven by higher operating income. Net cash provided by operating activities was $25.3 million, with $11.0 million in capital expenditures. The company repurchased 540,000 shares in 2024. For 2025, net sales are projected at $445 – $470 million, with adjusted EBITDA expected to be $38 – $44 million.

A conference call will be held today at 5:00 p.m. Eastern time to discuss the fourth quarter and full year 2024 results. Participants can join by calling the toll-free number 1-800-717-1738 or the international number 1-646-307-1865 with the conference ID 73865. The call will be broadcast live and available for replay on the company’s website. Nature’s Sunshine Products (Nasdaq: NATR) announces their fourth quarter and full year 2024 financial results. The earnings call will be held on Tuesday, March 11, 2025, at 4:30 p.m. Eastern Time. Toll-free replay available until March 25, 2025. International replay number: 1-412-317-6671, with Replay ID: 1173865.

Nature’s Sunshine Products operates in over 40 countries, manufacturing products in their own facilities to maintain quality. The company’s forward-looking statements include net sales and adjusted EBITDA outlook for 2025. Risks include government regulations, product liability claims, and economic conditions. Detailed risk factors can be found in reports filed with the SEC.

Non-GAAP financial measures like non-GAAP net income and adjusted EBITDA are used to evaluate operations. These measures provide insight into the company’s ability to fund business activities. However, they should not be seen as more significant than U.S. GAAP net income. Comparing these metrics with other companies may not give a complete picture of Nature’s Sunshine Products’ performance. Nature’s Sunshine Products, Inc. reported net sales of $118,205 in Q4 2024, up from $108,936 in Q4 2023. Gross profit was $85,064, with operating expenses of $36,805 for volume incentives and $43,709 for SG&A. Net income was ($732) with diluted EPS of ($0.02).

The company believes presenting net sales in local currency removes the impact of exchange rate changes, providing a more meaningful comparison of foreign operations. Adjusted EBITDA for 2024 was $10,267 in Q4, totaling $40,544 for the year. A reconciliation of GAAP net income to non-GAAP net income and adjusted EPS is provided in the financial tables.

Nature’s Sunshine Products’ balance sheet shows $160,579 in current assets and $79,864 in total liabilities as of December 31, 2024. Operating lease right-of-use assets were $12,799, with $114,577 in common stock and $57,407 in retained earnings.

The company reported net cash provided by operating activities of $25,298 in 2024, with net cash used in investing activities of $10,971 and net cash used in financing activities of $9,905. Cash and cash equivalents at the end of the year were $84,700.

For the year ended December 31, 2024, Nature’s Sunshine Products reconciled net income (loss) to adjusted EBITDA, with adjustments for depreciation, share-based compensation, other income (loss), and income taxes. Adjusted EBITDA was $10,267 in Q4 2024, totaling $40,544 for the year.



Read more at GlobeNewswire:: Nature’s Sunshine Reports Fourth Quarter and Full Year 2024